THE PHAGE

THE PHAGE, Inc., established on July 15, 2021, is a Tokyo-based startup focused on personalized healthcare. The company was founded by Shohei Tokunaga, who serves as the representative. THE PHAGE operates with a mission to create a "recommendation-based society rooted in biological needs" by analyzing the interplay between daily biometric data and lifestyle habits. This analysis allows them to offer personally optimized health recommendations.

The company's initial focus is on blood glucose levels, chosen for their high sensitivity to lifestyle factors like diet and exercise. Its primary product is Glucose Flight®, a comprehensive support system for individuals managing diabetes. This system provides personalized lifestyle recommendations by analyzing individual biometric data to propose optimized treatment indices, empowering users to manage their glucose levels more independently. Glucose Flight® also assists medical professionals in delivering precise nutritional guidance tailored to a patient's unique lifestyle. The business model includes providing this AI-based diabetes care system and offering R&D support services to other companies in the medical and healthcare sectors. These collaborations with medical and food manufacturers, such as TOPPAN and Meiji, aim to explore and develop innovative health foods and technologies.

THE PHAGE serves both individual users seeking to manage their health and corporate clients requiring R&D support for new health-related products and services. Revenue is generated through its diabetes care business and partnerships for R&D. In September 2024, the company secured pre-series A funding, led by Genesia Ventures, to advance the development of Glucose Flight® and expand its team. This investment underscores the firm's strategy to scale its AI-powered diabetes care operations and enhance its R&D support capabilities across the medical, food, and insurance industries.

Keywords: personalized healthcare, blood glucose monitoring, diabetes management, biometric data analysis, AI health recommendations, lifestyle optimization, digital therapeutics, R&D support, health technology, medical data, nutritional guidance, Glucose Flight, Shohei Tokunaga, Genesia Ventures, TOPPAN partnership, Meiji partnership, chronic disease management, AI in healthcare, preventative medicine, health and wellness platform